Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Coronavirus Disease 2019 and Antimicrobial Resistance: Parallel and Interacting Health Emergencies
Robby Nieuwlaat, Lawrence Mbuagbaw, Dominik Mertz, et al.
Clinical Infectious Diseases (2020) Vol. 72, Iss. 9, pp. 1657-1659
Open Access | Times Cited: 135

Showing 26-50 of 135 citing articles:

Co-Infections, Secondary Infections, and Antimicrobial Use in Patients Hospitalized with COVID-19 during the First Five Waves of the Pandemic in Pakistan; Findings and Implications
Kiran Ramzan, Sameen Shafiq, Iqra Raees, et al.
Antibiotics (2022) Vol. 11, Iss. 6, pp. 789-789
Open Access | Times Cited: 33
Semisynthetic Amides of Amphotericin B and Nystatin A1: A Comparative Study of In Vitro Activity/Toxicity Ratio in Relation to Selectivity to Ergosterol Membranes
Anna N. Tevyashova, Svetlana S. Efimova, Alexander I. Alexandrov, et al.
Antibiotics (2023) Vol. 12, Iss. 1, pp. 151-151
Open Access | Times Cited: 18
An insights into emerging trends to control the threats of antimicrobial resistance (AMR): an address to public health risks
Ayesha Asghar, Aneeza Khalid, Zulqarnain Baqar, et al.
Archives of Microbiology (2024) Vol. 206, Iss. 2
Closed Access | Times Cited: 7
Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics
Claire Mason, Tanmay Kanitkar, Charlotte Richardson, et al.
Journal of Antimicrobial Chemotherapy (2020) Vol. 76, Iss. 5, pp. 1323-1331
Open Access | Times Cited: 46
Integrated surveillance of antimicrobial resistance and antimicrobial use: Evaluation of the status in Canada (2014–2019)
Simon J. G. Otto, Margaret Haworth-Brockman, Misha Miazga-Rodriguez, et al.
Can J Public Health (2022) Vol. 113, Iss. 1, pp. 11-22
Open Access | Times Cited: 24
Application of Nanomaterials in the Prevention, Detection, and Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA)
John Hulme
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 805-805
Open Access | Times Cited: 23
Design, synthesis, molecular dynamic simulation studies, and antibacterial evaluation of new spirocyclic aminopyrimidines
Sherif S. Ragab, Mohamed Abdelraof, Ahmed A. El‐Rashedy, et al.
Journal of Molecular Structure (2023) Vol. 1278, pp. 134912-134912
Closed Access | Times Cited: 13
Antimicrobial activity of Monascus purpureus-derived red pigments against Salmonella typhimurium, Escherichia coli, and Enterococcus faecalis
Islam I. Teiba, Islam Mamdouh, Mokhtar I. Yousef, et al.
AMB Express (2025) Vol. 15, Iss. 1
Open Access
Evaluating the antibacterial efficacy of bee venom against multidrug-resistant pathogenic bacteria: Escherichia coli, Salmonella typhimurium, and Enterococcus faecalis
Emad H. El-Bilawy, Islam Mamdouh, Said I. Behiry, et al.
World Journal of Microbiology and Biotechnology (2025) Vol. 41, Iss. 2
Open Access
Delineating the impact of COVID-19 on antimicrobial resistance: An Indian perspective
P. S. Seethalakshmi, Oliver J. Charity, Theodoros Giakoumis, et al.
The Science of The Total Environment (2021) Vol. 818, pp. 151702-151702
Open Access | Times Cited: 29
Host factors facilitating SARS‐CoV‐2 virus infection and replication in the lungs
Sébastien Boutin, Dagmar Hildebrand, Steeve Boulant, et al.
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 16, pp. 5953-5976
Open Access | Times Cited: 28
Decreased Use of Broad-Spectrum Antibiotics During the Coronavirus Disease 2019 Epidemic in South Korea
Sukhyun Ryu, Youngsik Hwang, Sheikh Taslim Ali, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. 6, pp. 949-955
Open Access | Times Cited: 27
Is the Pendulum of Antimicrobial Drug Resistance Swinging Back after COVID-19?
Francesca Serapide, Angela Quirino, Vincenzo Scaglione, et al.
Microorganisms (2022) Vol. 10, Iss. 5, pp. 957-957
Open Access | Times Cited: 21
Resistome Study in Aquatic Environments
Hanseob Shin, Yong-Jin Kim, Seunggyun Han, et al.
Journal of Microbiology and Biotechnology (2022) Vol. 33, Iss. 3, pp. 277-287
Open Access | Times Cited: 21
Who should be screened for carbapenemase-producing Enterobacterales and when? A systematic review
Micky Ilan, Anne Kjerulf
Journal of Hospital Infection (2023) Vol. 142, pp. 74-87
Open Access | Times Cited: 11
The Acquisition of Multidrug-Resistant Bacteria in Patients Admitted to COVID-19 Intensive Care Units: A Monocentric Retrospective Case Control Study
Elisa Gouvêa Bogossian, Fabio Silvio Taccone, Antonio Izzi, et al.
Microorganisms (2020) Vol. 8, Iss. 11, pp. 1821-1821
Open Access | Times Cited: 27
Long-Term Study of Antibiotic Presence in Ebro River Basin (Spain): Identification of the Emission Sources
Samuel Moles, Sebastiano Gozzo, María P. Ormad, et al.
Water (2022) Vol. 14, Iss. 7, pp. 1033-1033
Open Access | Times Cited: 18
Tetrahedral Framework Nucleic Acids: A Novel Strategy for Antibiotic Treating Drug-Resistant Infections
Yue Sun, Xingyu Chen, Sirong Shi, et al.
Biomacromolecules (2023) Vol. 24, Iss. 2, pp. 1052-1060
Open Access | Times Cited: 9
Pathogen Distribution, Drug Resistance Risk Factors, and Construction of Risk Prediction Model for Drug-Resistant Bacterial Infection in Hospitalized Patients at the Respiratory Department During the COVID-19 Pandemic
Xiaolin Wei, Qianglin Zeng, Min Xie, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 1107-1121
Open Access | Times Cited: 9
Rational Design of Benzobisheterocycle Metallo-β-Lactamase Inhibitors: A Tricyclic Scaffold Enhances Potency against Target Enzymes
Valentina Villamil, María-Agustina Rossi, María F. Mojica, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 5, pp. 3795-3812
Closed Access | Times Cited: 3
Global Health Commodities Supply Chain in the Era of COVID-19 Pandemic: Challenges, Impacts, and Prospects: A Systematic Review
Zelalem Tilahun Mekonen, Teferi Gedif Fenta, Simon Peter Nadeem, et al.
Journal of Multidisciplinary Healthcare (2024) Vol. Volume 17, pp. 1523-1539
Open Access | Times Cited: 3
Antibiotic-Fe3O4 nanoparticles with highly efficient catalytic activity for enhanced chemiluminescence detection of tetracyclines residues in foods
Fei Yu, Binghua Fan, Yilin Chai, et al.
Food Chemistry X (2024) Vol. 22, pp. 101485-101485
Open Access | Times Cited: 3
Antibiotics in the Community During the COVID-19 Pandemic: A Qualitative Study to Understand Users’ Perspectives of Antibiotic Seeking and Consumption Behaviors in Bangladesh
Md Abul Kalam, Shahanaj Shano, Sharmin Afrose, et al.
Patient Preference and Adherence (2022) Vol. Volume 16, pp. 217-233
Open Access | Times Cited: 14
Evaluation of antibiotics resistance in Southern Iran in light of COVID‐19 pandemic: A retrospective observational study
Rahim Raoofi, Negin Namavari, Vahid Rahmanian, et al.
Health Science Reports (2023) Vol. 6, Iss. 3
Open Access | Times Cited: 8
Impact of antibiotic resistance on sustainable development goals
Meraim Attyah Kazaal, Weam Abbas Hamad, Wegdan Atiya, et al.
AIP conference proceedings (2023) Vol. 2776, pp. 020016-020016
Open Access | Times Cited: 8

Scroll to top